340B Orphan Drug Discounts Dialed Back

Law360, New York (October 14, 2015, 9:28 PM ET) -- The Affordable Care Act fully exempts orphan drugs from mandatory discounts under the 340B program for certain health care providers, a D.C. federal judge said Wednesday in an important victory for trade group Pharmaceutical Research and Manufacturers of America.



The decision from U.S. District Judge Rudolph Contreras vacated a rule issued last year by the U.S. Department of Health and Human Services. The rule interpreted the ACA as requiring discounts when orphan drugs are used for diseases that arenâ€™t rare, but PhRMA filed suit, arguing that...

To view the full article, register now.